Celcuity Inc.

US$66.79As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CELCHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR 20.48%
Div yield —
ROE (1192.88%)
Biotechnology
Beta (5Y) 0.13
PE TTM —
TSR TTM (13.44%)
Mkt cap US$3.268B
ROIC (27.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$76
13.25%
255.81%
Hold 9|3|10|9|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.35
1.35
1.37
1.34
28.04%
20.44%
10.27%
3.41%
Revenue$M
396.7
385.7
394.5
388.2
1.56%
(4.75%)
(0.58%)
(4.57%)
Peers (US$3.268B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.093
0.023
0.025
EBIT/Intx
0.831
0.470
0.439
Own earn%
103.70
167.27
167.03
Sh yield%
38.03
38.96
38.64
Owners
Insiders/Inst%
0.77
20.26
Short interest%
0.75
SBC / revenue%
4.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
22